1. Home
  2. LOAN vs ANL Comparison

LOAN vs ANL Comparison

Compare LOAN & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • ANL
  • Stock Information
  • Founded
  • LOAN 1989
  • ANL 2004
  • Country
  • LOAN United States
  • ANL Cayman Islands
  • Employees
  • LOAN N/A
  • ANL N/A
  • Industry
  • LOAN Real Estate Investment Trusts
  • ANL
  • Sector
  • LOAN Real Estate
  • ANL
  • Exchange
  • LOAN Nasdaq
  • ANL Nasdaq
  • Market Cap
  • LOAN 61.0M
  • ANL 61.8M
  • IPO Year
  • LOAN 1999
  • ANL 2023
  • Fundamental
  • Price
  • LOAN $4.95
  • ANL $1.54
  • Analyst Decision
  • LOAN
  • ANL Hold
  • Analyst Count
  • LOAN 0
  • ANL 1
  • Target Price
  • LOAN N/A
  • ANL N/A
  • AVG Volume (30 Days)
  • LOAN 43.7K
  • ANL 5.9K
  • Earning Date
  • LOAN 10-24-2025
  • ANL 11-11-2025
  • Dividend Yield
  • LOAN 9.33%
  • ANL N/A
  • EPS Growth
  • LOAN N/A
  • ANL N/A
  • EPS
  • LOAN 0.46
  • ANL N/A
  • Revenue
  • LOAN $7,138,128.00
  • ANL N/A
  • Revenue This Year
  • LOAN N/A
  • ANL N/A
  • Revenue Next Year
  • LOAN $4.47
  • ANL N/A
  • P/E Ratio
  • LOAN $10.65
  • ANL N/A
  • Revenue Growth
  • LOAN N/A
  • ANL N/A
  • 52 Week Low
  • LOAN $4.74
  • ANL $1.10
  • 52 Week High
  • LOAN $6.05
  • ANL $3.89
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 29.27
  • ANL 39.25
  • Support Level
  • LOAN $4.91
  • ANL $1.48
  • Resistance Level
  • LOAN $5.19
  • ANL $1.60
  • Average True Range (ATR)
  • LOAN 0.11
  • ANL 0.08
  • MACD
  • LOAN -0.04
  • ANL -0.02
  • Stochastic Oscillator
  • LOAN 8.08
  • ANL 24.00

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: